Home
/
Medications
/
KISQALI FEMARA CO-PACK

KISQALI FEMARA CO-PACK

Used for Cancer

View KISQALI FEMARA CO-PACK savings options available to you including Manufacturer Coupons, Rx Advantage Savings Card, Canadian Prescription Savings or KISQALI FEMARA CO-PACK Patient Assistance Program.

Programs are suitable for individuals who want to buy KISQALI FEMARA CO-PACK without insurance, with insurance or for those who are underinsured. You can pay as little as $0 per fill.*

Manufactured by Novartis Pharmaceuticals

*Applicable to Drug Coupons & Patient Assistance Programs

This content is intended for US audiences only

Drug savings programs

  • Qualified

    Rx Advantage Card

    A hand holding a dark-colored prescription savings card with various ID numbers and the label "Rx Advantage." Text below states the card is not insurance and cannot be used for Medicare or Medicaid.

    Save up to 90%

  • Unavailable

    Canadian Prescription Savings

    N/A
    Manufactured by
    N/A
    Powered by
    Prescription Help Logo
    Unavailable
  • Available

    Drug Coupons

    A hand holds a Copay Savings Card that states eligible patients with commercial insurance may pay as little as $0 per tube for Opzelura.

    Pay as little as $0

  • Available

    Patient Assistance Programs

    A picture of a patient assistance application form

    FREE

scrollable
Jamie Winn NowPatientGreen tick
Updated on 26 Apr 2024

Learn more about KISQALI FEMARA CO-PACK

What is KISQALI FEMARA CO-PACK?

What is KISQALI FEMARA CO-PACK?

KISQALI FEMARA CO-PACK is the brand name for ribociclib tablets letrozole oral tablets.

What dosages is KISQALI FEMARA CO-PACK available in?

What dosages is KISQALI FEMARA CO-PACK available in?

KISQALI FEMARA CO-PACK is copackaged containing:

  • KISQALI: 200 mg
  • FEMARA: 2.5 mg
What is KISQALI FEMARA CO-PACK used for?

What is KISQALI FEMARA CO-PACK used for?

KISQALI FEMARA CO-PACK, a co-packaged product containing ribociclib, a kinase inhibitor, and letrozole, an aromatase inhibitor, is indicated as initial endocrine-based therapy for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic
breast cancer.

How does KISQALI FEMARA CO-PACK work?

How does KISQALI FEMARA CO-PACK work?

KISQALI FEMARA CO-PACK contains two medications. Ribociclib works by slowing or stopping the growth of cancer cells. Letrozole works by decreasing the amount of estrogen the body makes, which helps slow down or reverse the growth of some breast cancers.

How do I take KISQALI FEMARA CO-PACK?

How do I take KISQALI FEMARA CO-PACK?

KISQALI FEMARA CO-PACK is dosed as follows:
KISQALI FEMARA CO-PACK contains both ribociclib and letrozole (an aromatase inhibitor) packaged together. It’s taken in a 1 month (28 days) cycle. For the first 3 weeks (21 days) of the cycle, the typical starting dose is 600 mg of ribociclib by mouth once daily. During the last week (7 days), you won’t take any ribociclib. At the end of the month, the cycle starts over again. During that last week when you aren’t taking ribociclib, you’ll still continue to use letrozole 2.5 mg by mouth daily.

Is it safe for me to take KISQALI FEMARA CO-PACK?

Is it safe for me to take KISQALI FEMARA CO-PACK?

KISQALI FEMARA CO-PACK is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.

KISQALI FEMARA CO-PACK Common Side Effects

KISQALI FEMARA CO-PACK Common Side Effects

Common side effects of KISQALI FEMARA CO-PACK:

  • Neutropenia
  • Nausea
  • Infections
  • Fatigue
  • Leukopenia
  • Diarrhea
  • Hair loss
  • Vomiting
  • Headache
  • Constipation
  • Back pain
  • Rash
  • Anemia
KISQALI FEMARA CO-PACK Serious Side Effects

KISQALI FEMARA CO-PACK Serious Side Effects

Serious side effects are rare with KISQALI FEMARA CO-PACK. Contact your healthcare provider immediately if you experience any of the following.

  • Lung problems: cough, trouble breathing, shortness of breath, chest pain
  • Severe skin reactions: severe rash or rash that keeps getting worse, reddened skin, flu-like symptoms, skin pain/burning, blistering of the lips, eyes or mouth,
    blisters on the skin or skin peeling, with or without fever
  • Heart rhythm problems (QT prolongation): change in your heartbeat (a fast or irregular heartbeat), or if you feel dizzy or faint
  • Liver problems: yellowing of your skin or the whites of your eyes (jaundice), dark or brown (tea-colored) urine, feeling very tired, loss of appetite, pain on the upper right side of your stomach area (abdomen)
  • Low white blood cell counts (neutropenia): symptoms of infections such as fever and chills
Effects of other drugs, drug classes and over-the-counter products on KISQALI FEMARA CO-PACK

Effects of other drugs, drug classes and over-the-counter products on KISQALI FEMARA CO-PACK

The following medications may interact with KISQALI FEMARA CO-PACK:

  • CYP3A4 Inhibitors: Avoid concomitant use of KISQALI FEMARA COPACK with strong CYP3A inhibitors. If strong inhibitors cannot be avoided, reduce KISQALI dose
  • CYP3A4 Inducers: Avoid concomitant use of KISQALI FEMARA COPACK with strong CYP3A inducers.
  • CYP3A Substrates: The dose of sensitive CYP3A substrates with narrow therapeutic indices may need to be reduced when given concurrently with KISQALI FEMARA CO-PACK
  • Drugs Known to Prolong QT Interval: Avoid concomitant use of drugs known to prolong QT interval, such as anti-arrhythmic medicines
Who makes KISQALI FEMARA CO-PACK?

Who makes KISQALI FEMARA CO-PACK?

Novartis Pharmaceuticals

Is KISQALI FEMARA CO-PACK safe in pregnancy?

Is KISQALI FEMARA CO-PACK safe in pregnancy?

KISQALI FEMARA CO-PACK can harm your unborn baby. If you are able to become pregnant, your healthcare provider should do a pregnancy test before you start treatment with KISQALI FEMARA CO-PACK. Females who are able to become pregnant and who take KISQALI FEMARA CO-PACK should use effective birth control during treatment and for at least 3 weeks after the last dose of KISQALI FEMARA CO-PACK. Talk to your healthcare provider about birth control methods that may be right for you during this time. If you become pregnant or think you are pregnant, tell your healthcare provider right away.

pill

What to do if you missed your KISQALI FEMARA CO-PACK dose

The FDA's medical product safety reporting program for health professionals, patients and consumers.

Learn more about reporting side effects
dollar sign

Drug Savings Tips

Medical Disclaimer

NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.

The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.

FAQ logo

People Asked

Now Patient Data Security

Data Security

Our Commitment to You.

Find out moreNow Patient Data SecurityNow Patient Data Security

What is NowPatient

Telehealth and Online Pharmacy

NowPatient is a licensed online pharmacy and doctor service that is available around the world. Our service is FREE and packed with valuable features that can benefit your health such as medication reminders, educational blogs, medically approved symptoms checker, UK NHS online pharmacyprivate treatment plansRx Advantage cardhealth conditions information, affordable medications options, genetic testinghome test kitshealth riskspollen meterair quality monitor, weight loss plans, drug savings programs and lots more!

A laptop screen displaying a health dashboard with widgets showing health profile, notifications, personalized health tools, and favorite widgets including body mass index and weight loss tracking.

WHY WE BUILT NOWPATIENT

To improve the lives of everyone by making high-quality care accessible and convenient

We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.

Download our app today

A collage showing a map with pharmacies, a questionnaire, medication details, and a person video chatting on a screen.

Can I trust NowPatient

Meet our medical team

We are a passionate group of clinicians and medical writers covering a broad range of specialities with experience operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process

Your Questions Answered

For your peace of mind, we can answer your questions quickly

We have a comprehensive list of FAQ’s on each feature page. Alternatively, for broader questions around our service just click the button below.
Find your answers